Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer

Cancer Res (2021) 81 (7): 1654–1666.

https://doi.org/10.1158/0008-5472.CAN-20-3021

Published: 01 April 2021

View article titled, Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer

Includes: Supplementary data

Journal Articles

Abstract P6-04-11: LLGL2 is involved in resistance to tamoxifen in estrogen receptor-alpha positive breast cancer patients

Tomoka Hisada, Naoto Kondo, Yumi Endo, Tomoko Asano, Yasuaki Uemoto, Sayaka Nishikawa, Yusuke Katagiri, Mitsuo Terada, Akiko Kato, Yu Dong, Hiroyuki Kato, Satoru Takahashi, Tatsuya Toyama

Cancer Res (2020) 80 (4_Supplement): P6-04-11.

https://doi.org/10.1158/1538-7445.SABCS19-P6-04-11

Published: 15 February 2020

View article titled, Abstract P6-04-11: LLGL2 is involved in resistance to tamoxifen in estrogen receptor-alpha positive breast cancer patients

Journal Articles

Abstract P6-07-03: The prognostic impact of HECTD1 E3 ubiquitin ligase expression in breast cancer patients

Yasuaki Uemoto, Naoto Kondo, Yumi Wanifuchi-Endo, Tomoko Asano, Tomoka Hisada, Sayaka Nishikawa, Yusuke Katagiri, Mitsuo Terada, Akiko Kato, Yu Dong, Hiroyuki Kato, Satoru Takahashi, Tatsuya Toyama

Cancer Res (2020) 80 (4_Supplement): P6-07-03.

https://doi.org/10.1158/1538-7445.SABCS19-P6-07-03

Published: 15 February 2020

View article titled, Abstract P6-07-03: The prognostic impact of HECTD1 E3 ubiquitin ligase expression in breast cancer patients

Journal Articles

Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-Wild-Type Diffuse Astrocytic Gliomas

Cancer Res (2019) 79 (19): 4814–4827.

https://doi.org/10.1158/0008-5472.CAN-19-1272

Published: 01 October 2019

View article titled, Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-Wild-Type Diffuse Astrocytic Gliomas

Includes: Supplementary data

Journal Articles

Abstract 261: Chemopreventive effects of flavonoids on pancreatic carcinogenesis

Hiroyuki Kato, Aya Naiki, Shugo Suzuki, Yoriko Yamashita, Satoru Takahashi

Cancer Res (2018) 78 (13_Supplement): 261.

https://doi.org/10.1158/1538-7445.AM2018-261

Published: 01 July 2018

View article titled, Abstract 261: Chemopreventive effects of flavonoids on pancreatic carcinogenesis

Journal Articles

Abstract 254: Chemopreventive effects of angiotensin II receptor type 2 agonist on prostate carcinogenesis by the downregulation of the androgen receptor

Hiroji Uemura, Yusuke Ito, Aya Naiki-Ito, Hiroyuki Kato, Shugo Suzuki, Toshiya Kuno, Satoru Takahashi

Cancer Res (2018) 78 (13_Supplement): 254.

https://doi.org/10.1158/1538-7445.AM2018-254

Published: 01 July 2018

View article titled, Abstract 254: Chemopreventive effects of angiotensin II receptor type 2 agonist on prostate carcinogenesis by the downregulation of the androgen receptor

Journal Articles

Abstract 1110: Inhibition of histone deacetylase induces miR-320-mediated androgen receptor suppression in prostate cancer

Shinya Sato, Keisuke Katsushima, Keiko Shinjo, Satoru Takahashi, Yutaka Kondo

Cancer Res (2016) 76 (14_Supplement): 1110.

https://doi.org/10.1158/1538-7445.AM2016-1110

Published: 15 July 2016

View article titled, Abstract 1110: Inhibition of histone deacetylase induces miR-320-mediated androgen receptor suppression in prostate cancer

Journal Articles

Histone Deacetylase Inhibition in Prostate Cancer Triggers miR-320–Mediated Suppression of the Androgen Receptor

Shinya Sato, Keisuke Katsushima, Keiko Shinjo, Akira Hatanaka, Fumiharu Ohka, Shugo Suzuki, Aya Naiki-Ito, Norihito Soga, Satoru Takahashi, Yutaka Kondo

Cancer Res (2016) 76 (14): 4192–4204.

https://doi.org/10.1158/0008-5472.CAN-15-3339

Published: 14 July 2016

View article titled, Histone Deacetylase Inhibition in Prostate Cancer Triggers miR-320–Mediated Suppression of the Androgen Receptor

Includes: Supplementary data

Journal Articles

Abstract P5-05-02: Prognostic impact of single-nucleotide polymorphisms (SNPs) in or near the ZNF423 and CTSO genes in estrogen receptor (ER)-positive breast cancer patients receiving adjuvant endocrine therapy

Yukari Hato, Yumi Endo, Nobuyasu Yoshimoto, Tomoko Asano, Mina Yamaguchi, Satoru Takahashi, Tatsuya Toyama

Cancer Res (2015) 75 (9_Supplement): P5-05-02.

https://doi.org/10.1158/1538-7445.SABCS14-P5-05-02

Published: 01 May 2015

View article titled, Abstract P5-05-02: Prognostic impact of single-nucleotide polymorphisms (SNPs) in or near the ZNF423 and CTSO genes in estrogen receptor (ER)-positive breast cancer patients receiving adjuvant endocrine therapy

Journal Articles

Abstract P4-11-22: High expression of LMTK3 is an independent factor indicating a poor prognosis in Japanese estrogen receptor α-positive breast cancer patients

Tatsuya Toyama, Tomoko Asano, Shinya Sato, Nobuyasu Yoshimoto, Yumi Endo, Yukari Hato, Dong Yu, Satoru Takahashi, Yoshitaka Fujii

Cancer Res (2015) 75 (9_Supplement): P4-11-22.

https://doi.org/10.1158/1538-7445.SABCS14-P4-11-22

Published: 01 May 2015

View article titled, Abstract P4-11-22: High expression of LMTK3 is an independent factor indicating a poor prognosis in Japanese estrogen receptor α-positive breast cancer patients

Journal Articles

Abstract P4-07-04: Immunohistochemical determination of arylamine N-acetyltransferase 1 (NAT1) as the target of miR-1290 and prognostic biomarker of breast cancer

Yumi Endo, Hiroko Yamashita, Satoru Takahashi, Shinya Sato, Nobuyasu Yoshimoto, Tomoko Asano, Yukari Hato, Mina Yamaguchi, Yu Dong, Tatsuya Toyama

Cancer Res (2015) 75 (9_Supplement): P4-07-04.

https://doi.org/10.1158/1538-7445.SABCS14-P4-07-04

Published: 01 May 2015

View article titled, Abstract P4-07-04: Immunohistochemical determination of arylamine N-acetyltransferase 1 (NAT1) as the target of miR-1290 and prognostic biomarker of breast cancer

Journal Articles

CtBP2 Modulates the Androgen Receptor to Promote Prostate Cancer Progression

Ken-ichi Takayama, Takashi Suzuki, Tetsuya Fujimura, Tomohiko Urano, Satoru Takahashi, Yukio Homma, Satoshi Inoue

Cancer Res (2014) 74 (22): 6542–6553.

https://doi.org/10.1158/0008-5472.CAN-14-1030

Published: 13 November 2014

View article titled, CtBP2 Modulates the Androgen Receptor to Promote Prostate Cancer Progression

Includes: Supplementary data

Journal Articles

Chromatin Regulator PRC2 Is a Key Regulator of Epigenetic Plasticity in Glioblastoma

Atsushi Natsume, Motokazu Ito, Keisuke Katsushima, Fumiharu Ohka, Akira Hatanaka, Keiko Shinjo, Shinya Sato, Satoru Takahashi, Yuta Ishikawa, Ichiro Takeuchi, Hiroki Shimogawa, Motonari Uesugi, Hideyuki Okano, Seung U. Kim, Toshihiko Wakabayashi, Jean-Pierre J. Issa, Yoshitaka Sekido, Yutaka Kondo

Cancer Res (2013) 73 (14): 4559–4570.

https://doi.org/10.1158/0008-5472.CAN-13-0109

Published: 15 July 2013

View article titled, Chromatin Regulator PRC2 Is a Key Regulator of Epigenetic Plasticity in Glioblastoma

Includes: Supplementary data

Journal Articles

Abstract 5375: Androgen excess induces aberrant DNA methylation in the prostate.

Satoshi Yamashita, Satoru Takahashi, Yasunori Matsuda, Ken Gyobu, Toshikazu Ushijima

Cancer Res (2013) 73 (8_Supplement): 5375.

https://doi.org/10.1158/1538-7445.AM2013-5375

Published: 15 April 2013

View article titled, Abstract 5375: Androgen excess induces aberrant DNA methylation in the prostate.

Journal Articles

Abstract 672: Histone deacetylase inhibition has potential to suppresse growth of androgen dependent and independent prostate cancer in vitro and in vivo.

Shinya Sato, Shugo Suzuki, Aya Naiki-Ito, Yoriko Yamashita, Makoto Asamoto, Tomoyuki Shirai, Satoru Takahashi

Cancer Res (2013) 73 (8_Supplement): 672.

https://doi.org/10.1158/1538-7445.AM2013-672

Published: 15 April 2013

View article titled, Abstract 672: Histone deacetylase inhibition has potential to suppresse growth of androgen dependent and independent prostate cancer in vitro and in vivo.

Journal Articles

Abstract 3284: Organ-specific Gst-pi expression in new metastatic androgen-independent prostate cancer animal model

Taku Naiki, Makoto Asamoto, Aya Naiki-Ito, Kenji Yamada, Ryosuke Ando, Youichi Ikegami, Noriyasu Kawai, Keiichi Tozawa, Satoru Takahashi, Kenjiro Kohri

Cancer Res (2012) 72 (8_Supplement): 3284.

https://doi.org/10.1158/1538-7445.AM2012-3284

Published: 15 April 2012

View article titled, Abstract 3284: Organ-specific Gst-pi expression in new metastatic androgen-independent prostate cancer animal model

Journal Articles

Abstract 893: Anticancer effect and mechanism of prostaglandin E2 receptor EP4 antagonist

Kazuhiko Nonomura, Katsuyoshi Miyama, Kiyoshi Kanazawa, Takako Okumura, Yoshiyuki Okumura, Masanobu Oshima, Satoru Takahashi, Yukinori Take

Cancer Res (2012) 72 (8_Supplement): 893.

https://doi.org/10.1158/1538-7445.AM2012-893

Published: 15 April 2012

View article titled, Abstract 893: Anticancer effect and mechanism of prostaglandin E2 receptor EP4 antagonist

Journal Articles

Abstract 4980: Age dependent carcinogenic susceptibility of rat liver is related to potential of gap junctional intercellular communication

Aya Naiki-Ito, Makoto Asamoto, Satoru Takahashi, Tomoyuki Shirai

Cancer Res (2012) 72 (8_Supplement): 4980.

https://doi.org/10.1158/1538-7445.AM2012-4980

Published: 15 April 2012

View article titled, Abstract 4980: Age dependent carcinogenic susceptibility of rat liver is related to potential of gap junctional intercellular communication

Journal Articles

A Novel Transgenic Mouse Model of the Human Multiple Myeloma Chromosomal Translocation t(14;16)(q32;q23)

Naoki Morito, Keigyou Yoh, Atsuko Maeda, Takako Nakano, Akiko Fujita, Manabu Kusakabe, Michito Hamada, Takashi Kudo, Kunihiro Yamagata, Satoru Takahashi

Cancer Res (2011) 71 (2): 339–348.

https://doi.org/10.1158/0008-5472.CAN-10-1057

Published: 13 January 2011

View article titled, A Novel Transgenic Mouse Model of the Human Multiple Myeloma Chromosomal Translocation t(14;16)(q32;q23)

Journal Articles

Abstract 1705: 14-3-3ζ is an androgen-regulated gene that activates the androgen receptor signaling and facilitates cell survival in prostate cancer

Taro Murata, Ken-ichi Takayama, Tomohiko Urano, Tetsuya Fujimura, Jinpei Kumagai, Kuniko Horie-Inoue, Kazuhiro Ikeda, Satoru Takahashi, Yasuyoshi Ouchi, Yukio Homma, Satoshi Inoue

Cancer Res (2010) 70 (8_Supplement): 1705.

https://doi.org/10.1158/1538-7445.AM10-1705

Published: 15 April 2010

View article titled, Abstract 1705: 14-3-3ζ is an androgen-regulated gene that activates the androgen receptor signaling and facilitates cell survival in prostate cancer

NARROW

Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer

Abstract P6-04-11: LLGL2 is involved in resistance to tamoxifen in estrogen receptor-alpha positive breast cancer patients

Abstract P6-07-03: The prognostic impact of HECTD1 E3 ubiquitin ligase expression in breast cancer patients

Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-Wild-Type Diffuse Astrocytic Gliomas

Abstract 261: Chemopreventive effects of flavonoids on pancreatic carcinogenesis

Abstract 254: Chemopreventive effects of angiotensin II receptor type 2 agonist on prostate carcinogenesis by the downregulation of the androgen receptor

Abstract 1110: Inhibition of histone deacetylase induces miR-320-mediated androgen receptor suppression in prostate cancer

Histone Deacetylase Inhibition in Prostate Cancer Triggers miR-320–Mediated Suppression of the Androgen Receptor

Abstract P5-05-02: Prognostic impact of single-nucleotide polymorphisms (SNPs) in or near the ZNF423 and CTSO genes in estrogen receptor (ER)-positive breast cancer patients receiving adjuvant endocrine therapy

Abstract P4-11-22: High expression of LMTK3 is an independent factor indicating a poor prognosis in Japanese estrogen receptor α-positive breast cancer patients

Abstract P4-07-04: Immunohistochemical determination of arylamine N-acetyltransferase 1 (NAT1) as the target of miR-1290 and prognostic biomarker of breast cancer

CtBP2 Modulates the Androgen Receptor to Promote Prostate Cancer Progression

Chromatin Regulator PRC2 Is a Key Regulator of Epigenetic Plasticity in Glioblastoma

Abstract 5375: Androgen excess induces aberrant DNA methylation in the prostate.

Abstract 672: Histone deacetylase inhibition has potential to suppresse growth of androgen dependent and independent prostate cancer in vitro and in vivo.

Abstract 3284: Organ-specific Gst-pi expression in new metastatic androgen-independent prostate cancer animal model

Abstract 893: Anticancer effect and mechanism of prostaglandin E2 receptor EP4 antagonist

Abstract 4980: Age dependent carcinogenic susceptibility of rat liver is related to potential of gap junctional intercellular communication

A Novel Transgenic Mouse Model of the Human Multiple Myeloma Chromosomal Translocation t(14;16)(q32;q23)

Abstract 1705: 14-3-3ζ is an androgen-regulated gene that activates the androgen receptor signaling and facilitates cell survival in prostate cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only